ARTIFICIAL TEARS SOLUTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2D226F3141 for the delivery of ARTIFICIAL TEARS SOLUTION, identified by NSN 6505009617486 and PR 7017699502, with a total contract value of $19.80. The award was issued on July 30, 2026, and falls under the broader delivery order SPE2DX25D9822, indicating this is a small-scale procurement within a larger logistics framework. The contract is classified as a federal award with no specified set-aside or NAICS code, and performance is expected to support U.S. Department of Defense requirements, though no specific delivery location is provided. The awardee, identified by CAGE code 1UNB0, is a pharmaceutical supplier contracted through DIBBS, the Defense Logistics Agency’s procurement portal, and all contractual details are accessible via the official UI link associated with the award.
General Info
Agency
Contract Value
$19.8NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
